ARTICLE | Clinical News
Paquinimod regulatory update
August 22, 2011 7:00 AM UTC
In February, EMA granted Orphan Drug designation for Active Biotech's paquinimod to treat systemic sclerosis. The small molecule quinoline-3-carboxamide immunomodulator is slated to begin Phase IIa te...